Form D · Private Equity Fund

OrbiMed Private Investments X, LP

New York, NY · CIK 0002087033

Offering snapshot reported Oct 16, 2026 · SEC filing

Reported sold: $1.92B
Investors reported: 131
Minimum accepted: $0
First sale: Sep 30, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$1,669,183,000 → $1,921,099,472
Reported investors119 → 131

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 16, 2026	Amendment	$1,921,099,472	$251,916,472vs Apr 30, 2026	131	SEC filing
Apr 30, 2026	Amendment	$1,669,183,000	No comparison	119	SEC filing
Sep 29, 2025	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-559153

The total amount sold includes capital committed by the General Partner.

Paid based on a percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
UBS Switzerland AG	None
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691

Source: Form D, filed Oct 16, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED PRIVATE INVESTMENTS X, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value: $1.57B
Beneficial owners: 209
ADV minimum commitment: $1M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV (CAYMAN) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP NEW YORK, New York, United States

Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Marketer UBS FINANCIAL SERVICES INC. WEEHAWKEN, New Jersey, United States Related to adviser: No

Marketer UBS SWITZERLAND AG ZURICH, Switzerland Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LLP
PCAOB 185

UBS FINANCIAL SERVICES INC.
CRD 8174 · SEC 801-7163

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-6844581239

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Mona Ashiya	Executive
David P. Bonita	Executive
Sven H. Borho	Executive
Carl L. Gordon	Executive
Geoffrey C. Hsu	Executive
W. Carter Neild	Executive
N/A Orbi Med Advisors Llc	Executive
N/A Orbi Med Capital Gp X Llc	Executive
N/A Orbi Med Capital Gp X, Lp	Executive
Matthew S. Rizzo	Executive
C. Scotland Stevens	Executive
Peter A. Thompson	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

601 Lexington Avenue 54 Th Floor
New York, NY, 10022